Quadrant Capital Group LLC Novartis Ag Transaction History
Quadrant Capital Group LLC
- $2.65 Billion
- Q1 2025
A detailed history of Quadrant Capital Group LLC transactions in Novartis Ag stock. As of the latest transaction made, Quadrant Capital Group LLC holds 64,977 shares of NVS stock, worth $7.27 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
64,977
Previous 18,100
258.99%
Holding current value
$7.27 Million
Previous $1.76 Million
311.3%
% of portfolio
0.27%
Previous 0.12%
Shares
32 transactions
Others Institutions Holding NVS
# of Institutions
1,524Shares Held
142MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.32 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.16 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$963 Million0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$789 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$757 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $241B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...